94 related articles for article (PubMed ID: 20236737)
1. Self-organizing molecular field analysis of 2,4-thiazolidinediones: A 3D-QSAR model for the development of human PTP1B inhibitors.
Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
Eur J Med Chem; 2010 Jun; 45(6):2537-46. PubMed ID: 20236737
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR studies on a series of 2,4-thiazolidinedione derivatives: a self- organizing molecular field analysis approach to design novel PTP 1B inhibitors.
Malla P; Kumar M
Med Chem; 2013 Sep; 9(6):828-45. PubMed ID: 22974292
[TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR studies on unsaturated 4-azasteroids as human 5alpha-reductase inhibitors: a self organizing molecular field analysis approach.
Aggarwal S; Thareja S; Bhardwaj TR; Kumar M
Eur J Med Chem; 2010 Feb; 45(2):476-81. PubMed ID: 19906465
[TBL] [Abstract][Full Text] [Related]
4. Sulphonamides as inhibitors of protein tyrosine phosphatase 1B: a three-dimensional quantitative structure-activity relationship study using self-organizing molecular field analysis approach.
Thareja S; Kokil GR; Aggarwal S; Bhardwaj TR; Kumar M
Chem Pharm Bull (Tokyo); 2010 Apr; 58(4):526-32. PubMed ID: 20410637
[TBL] [Abstract][Full Text] [Related]
5. Cheminformatics based 3D-QSAR study on a series of 1,2-naphthoquinone derivatives as PTP 1B inhibitors.
Pahwa P; Papreja M
Acta Pol Pharm; 2012; 69(3):535-43. PubMed ID: 22594268
[TBL] [Abstract][Full Text] [Related]
6. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
Pandey G; Saxena AK
J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR studies on a series of 5-arylidine-2, 4-thiazolidinediones as aldose reductase inhibitors: a self-organizing molecular field analysis approach.
Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
Med Chem; 2010 Jan; 6(1):30-6. PubMed ID: 20402658
[TBL] [Abstract][Full Text] [Related]
8. Studies of the mechanism of selectivity of protein tyrosine phosphatase 1B (PTP1B) bidentate inhibitors using molecular dynamics simulations and free energy calculations.
Fang L; Zhang H; Cui W; Ji M
J Chem Inf Model; 2008 Oct; 48(10):2030-41. PubMed ID: 18831546
[TBL] [Abstract][Full Text] [Related]
9. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
Park H; Bhattarai BR; Ham SW; Cho H
Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects.
Bhattarai BR; Kafle B; Hwang JS; Khadka D; Lee SM; Kang JS; Ham SW; Han IO; Park H; Cho H
Bioorg Med Chem Lett; 2009 Nov; 19(21):6161-5. PubMed ID: 19783142
[TBL] [Abstract][Full Text] [Related]
11. 2,4-Thiazolidinediones as PTP 1B Inhibitors: A Mini Review (2012-2018).
Verma SK; Yadav YS; Thareja S
Mini Rev Med Chem; 2019; 19(7):591-598. PubMed ID: 30968766
[TBL] [Abstract][Full Text] [Related]
12. Effects of variable docking conditions and scoring functions on corresponding protein-aligned comparative molecular field analysis models constructed from diverse human protein tyrosine phosphatase 1B inhibitors.
Taha MO; AlDamen MA
J Med Chem; 2005 Dec; 48(25):8016-34. PubMed ID: 16335926
[TBL] [Abstract][Full Text] [Related]
13. Molecular docking and 3D-QSAR on 2-(oxalylamino) benzoic acid and its analogues as protein tyrosine phosphatase 1B inhibitors.
Zhou M; Ji M
Bioorg Med Chem Lett; 2005 Dec; 15(24):5521-5. PubMed ID: 16230012
[TBL] [Abstract][Full Text] [Related]
14. The antidiabetic drug lobeglitazone has the potential to inhibit PTP1B activity.
Rocha RF; Rodrigues T; Menegatti ACO; Bernardes GJL; Terenzi H
Bioorg Chem; 2020 Jul; 100():103927. PubMed ID: 32422389
[TBL] [Abstract][Full Text] [Related]
15. 5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases.
Maccari R; Paoli P; Ottanà R; Jacomelli M; Ciurleo R; Manao G; Steindl T; Langer T; Vigorita MG; Camici G
Bioorg Med Chem; 2007 Aug; 15(15):5137-49. PubMed ID: 17543532
[TBL] [Abstract][Full Text] [Related]
16. Self-organizing molecular field analysis on pregnane derivatives as human steroidal 5alpha-reductase inhibitors.
Aggarwal S; Thareja S; Bhardwaj TR; Kumar M
Steroids; 2010 Jun; 75(6):411-8. PubMed ID: 20170668
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional quantitative structure-activity relationships (3D-QSAR) of antidiabetic thiazolidinediones.
Kurogi Y
Drug Des Discov; 1999 Aug; 16(2):109-18. PubMed ID: 10533807
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
Koren S; Fantus IG
Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and docking study of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as inhibitors of protein tyrosine phosphatase 1B.
Wang Z; Liu Z; Lee W; Kim SN; Yoon G; Cheon SH
Bioorg Med Chem Lett; 2014 Aug; 24(15):3337-40. PubMed ID: 24953600
[TBL] [Abstract][Full Text] [Related]
20. Self organizing molecular field analysis on a series of human 5alpha-reductase inhibitors: unsaturated 3-carboxysteroid.
Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
Eur J Med Chem; 2009 Dec; 44(12):4920-5. PubMed ID: 19716209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]